PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Unveils Enhanced Instrumentation for High-Throughput Tissue Processing - Thermo Fisher Scientific, Inc., the world leader in serving science, today announced its latest STP 420ES™ tissue processor for use in high-volume pathology laboratories (NYSE: TMO)
Thermo Fisher Scientific Unveils Enhanced Instrumentation for High-Throughput Tissue Processing

 

NewswireToday - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2010/06/24 - Thermo Fisher Scientific, Inc., the world leader in serving science, today announced its latest STP 420ES™ tissue processor for use in high-volume pathology laboratories (NYSE: TMO).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The updated instrument features more robust hardware and ease-of-use, enabling the high-throughput processing of large volumes of tissue to meet the demands of today’s laboratories.

The Thermo Scientific STP 420ES models are designed to accommodate the most demanding requirements of researchers and pathologists in the field of tissue processing and have become an essential part of the laboratory workflow. The latest STP 420ES has been updated to include more robust hardware to handle the increasing number of samples processed in modern laboratories. The instrument’s dual chambers allow it to perform simultaneous or independent processing of up to 420 tissue cassettes, enabling higher throughput. In addition, ultimate fluid exchange is ensured by the innovative rotational movement of the main chamber. Rotational agitation is also up to seven-times more effective than conventional tidal agitation, eliminating the need for reprocessing.

The latest STP 420ES tissue processor can be combined with Fast Flex™ reagents to create a streamlined processing system, increasing throughput while maintaining tissue integrity. The Thermo Scientific Fast Flex tissue processing reagents combine the stability of traditional reagent technologies with the unique features of the STP 420ES to generate same-day-results. Additionally, Fast Flex reagents are easy to use, reducing labor burdens and drastically increasing fluid exchange, resulting in better processed tissue samples.

Further enhancements made to the STP 420ES include optimized user guiding software and touch screen operation. The STP 420ES is also supported by improved user documentation including user training manuals and quick reference guides to aid daily operation. With the introduction of its latest tissue processor, Thermo Fisher continues to offer excellent training to customers, ensuring instrument dependability.

Peter Brooks, the company’s international product manager for Anatomical Pathology in Europe, the Middle East and Asia Pacific, comments: “We are pleased to unveil the latest STP 420ES tissue processor, an easy-to-use instrument that features more robust software than previous models to enable increased throughput. The modern laboratory demands that tissue is processed efficiently and accurately in the shortest possible time and that instruments are user-friendly. The STP 420ES combines speed with ease-of-use and reinforces Thermo Fisher’s position as leading provider of instruments for high-quality tissue processing.”

Thermo Scientific is part of Thermo Fisher Scientific, Inc.

About Thermo Fisher Scientific
Thermo Fisher Scientific, Inc. (thermoscientific.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Unveils Enhanced Instrumentation for High-Throughput Tissue Processing

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Scottpr.com 
+44 1477 539539 pathology[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)